SEC Company Response from SUTRO BIOPHARMA, INC. (STRO) (CIK 0001382101) (STRO) — Sep 24, 2018
SUTRO BIOPHARMA, INC. (STRO) (CIK 0001382101)
Date: Sept. 24, 2018 · CIK: 0001382101 · Accession: 0001193125-18-281129
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227103
Letter
September 24, 2018
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: John Reynolds, Assistant Director
Irene Barberena-Meissner, Staff Attorney
Kevin Dougherty, Staff Attorney
Ethan Horowitz, Accounting Branch Chief
Wei Lu, Staff Accountant
Re: Sutro Biopharma, Inc.
Registration Statement on Form S-1 (File No. 333-227103)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 17, 2018 and the date hereof, approximately 675 copies of the Preliminary Prospectus dated September 17, 2018 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, September 26, 2018 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
COWEN AND COMPANY, LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 24, 2018 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: John Reynolds, Assistant Director Irene Barberena-Meissner, Staff Attorney Kevin Dougherty, Staff Attorney Ethan Horowitz, Accounting Branch Chief Wei Lu, Staff Accountant Re: Sutro Biopharma, Inc. Registration Statement on Form S-1 (File No. 333-227103) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 17, 2018 and the date hereof, approximately 675 copies of the Preliminary Prospectus dated September 17, 2018 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, September 26, 2018 or as soon thereafter as practicable. [Signature page follows] Very truly yours, COWEN AND COMPANY, LLC PIPER JAFFRAY & CO. As representatives of the Underwriters By: Cowen and Company, LLC By: /s/ Jason Fenton Name: Jason Fenton Title: Managing Director By: Piper Jaffray & Co. By: /s/ Neil Riley Name: Neil Riley Title: Managing Director